P K Buamah

463 total citations
20 papers, 333 citations indexed

About

P K Buamah is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P K Buamah has authored 20 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Hepatology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P K Buamah's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Ovarian cancer diagnosis and treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). P K Buamah is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Ovarian cancer diagnosis and treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). P K Buamah collaborates with scholars based in United Kingdom and Nigeria. P K Buamah's co-authors include A. W. Skillen, Oliver James, A. Milford Ward, Rebecca Harris, James S. Welsh, G. A. Turner, David Guthrie, H H Bain, Peter L. Morrell and G. R. Sutherland and has published in prestigious journals such as Clinical Chemistry, Journal of Clinical Pathology and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

P K Buamah

20 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P K Buamah United Kingdom 11 99 59 55 50 45 20 333
M A Cuadrado Spain 11 128 1.3× 53 0.9× 15 0.3× 39 0.8× 54 1.2× 23 419
Halil Ateş Türkiye 12 114 1.2× 25 0.4× 46 0.8× 19 0.4× 82 1.8× 31 368
Ronald W. Raven United Kingdom 13 111 1.1× 121 2.1× 21 0.4× 24 0.5× 122 2.7× 43 463
Sonja Skoupy Austria 10 88 0.9× 51 0.9× 14 0.3× 21 0.4× 40 0.9× 12 368
Harris Jw United States 11 52 0.5× 37 0.6× 29 0.5× 8 0.2× 42 0.9× 18 483
Takuji Miyoshi Japan 11 190 1.9× 20 0.3× 24 0.4× 21 0.4× 82 1.8× 43 438
Ratna Paul Finland 9 34 0.3× 46 0.8× 33 0.6× 27 0.5× 50 1.1× 26 330
H Yaneva France 11 157 1.6× 54 0.9× 7 0.1× 62 1.2× 67 1.5× 19 664
Ralph H. Starkey United States 7 193 1.9× 144 2.4× 21 0.4× 12 0.2× 101 2.2× 8 504
Takuji Nishisato Japan 10 108 1.1× 12 0.2× 125 2.3× 14 0.3× 41 0.9× 23 671

Countries citing papers authored by P K Buamah

Since Specialization
Citations

This map shows the geographic impact of P K Buamah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P K Buamah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P K Buamah more than expected).

Fields of papers citing papers by P K Buamah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P K Buamah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P K Buamah. The network helps show where P K Buamah may publish in the future.

Co-authorship network of co-authors of P K Buamah

This figure shows the co-authorship network connecting the top 25 collaborators of P K Buamah. A scholar is included among the top collaborators of P K Buamah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P K Buamah. P K Buamah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buamah, P K, et al.. (1990). Neuron‐specific enolase during chemotherapy of small cell lung cancer. Journal of Surgical Oncology. 44(1). 1–4. 11 indexed citations
2.
Buamah, P K, Paul M. Johnson, & A. W. Skillen. (1988). Comparative Study of the Clinical Usefulness of Prostate Specific Antigen and Prostatic Acid Phosphatase in Prostatic Disease. British Journal of Urology. 62(6). 581–583. 9 indexed citations
3.
Skillen, A. W., et al.. (1988). Urinary protein and enzyme excretion in patients receiving chemotherapy with the cis-platinum analogs carboplatin (CBDCA, JM8) and iproplatin (CHIP, JM9). Cancer Chemotherapy and Pharmacology. 22(3). 228–234. 5 indexed citations
4.
Buamah, P K, Oliver James, A. W. Skillen, & Adrian L. Harris. (1988). The value of tumour marker kinetics in the management of patients with primary hepatocellular carcinoma. Journal of Surgical Oncology. 37(3). 161–164. 7 indexed citations
5.
Buamah, P K, et al.. (1987). Initial assessment of tumor-associated antigen CA-125 in patients with ovarian, cervical, and testicular tumors.. Clinical Chemistry. 33(7). 1124–1125. 7 indexed citations
6.
Abel, P D, et al.. (1987). Assessment of Serum CA 19.9 as a Tumour Marker in Patients with Carcinoma of the Bladder and Prostate. British Journal of Urology. 59(5). 427–429. 21 indexed citations
7.
Buamah, P K, Peter McArdle, Mark K. Bennett, Oliver James, & R Lendrum. (1986). A pleomorphic hepatocellular carcinoma with biochemical features of fibrolamellar hepatocellular carcinoma. Journal of Surgical Oncology. 32(2). 93–95. 3 indexed citations
8.
Buamah, P K, et al.. (1986). Serum alpha fetoprotein kinetics in hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 16(1). 75–7. 2 indexed citations
9.
Buamah, P K, et al.. (1986). Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy. Cancer Chemotherapy and Pharmacology. 17(2). 182–184. 6 indexed citations
10.
Buamah, P K, Rebecca Harris, Oliver James, & A. W. Skillen. (1986). Lentil-lectin-reactive alpha-fetoprotein in the differential diagnosis of benign and malignant liver disease.. Clinical Chemistry. 32(11). 2083–2084. 35 indexed citations
12.
Buamah, P K & A. W. Skillen. (1985). Concentrations of protease and anti-protease in serum of patients with pancreatic cancer.. Clinical Chemistry. 31(6). 876–877. 15 indexed citations
13.
14.
Buamah, P K, et al.. (1984). Serum copper concentration significantly less in abnormal pregnancies.. Clinical Chemistry. 30(10). 1676–1677. 20 indexed citations
15.
Buamah, P K, et al.. (1984). Affinity chromatography used in distinguishing alpha-fetoprotein in serum from patients with tumors of hepatic parenchyma and of germ cells.. PubMed. 30(7). 1257–8. 14 indexed citations
16.
Buamah, P K, et al.. (1984). Maternal zinc status: a determination of central nervous system malformation. BJOG An International Journal of Obstetrics & Gynaecology. 91(8). 788–790. 48 indexed citations
17.
Morrell, Peter L., et al.. (1983). Lithium toxicity in a neonate.. Archives of Disease in Childhood. 58(7). 539–541. 28 indexed citations
18.
Buamah, P K, et al.. (1982). Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma. Cancer Chemotherapy and Pharmacology. 8(3). 281–4. 19 indexed citations
19.
Buamah, P K, Anthony Howell, & C.E. Newman. (1981). Cisplatin in patients with a non-functioning kidney. European Journal of Cancer and Clinical Oncology. 17(8). 933–934. 1 indexed citations
20.
Buamah, P K, Peter R. Taylor, & A M Ward. (1981). Concanavalin A binding of alpha-fetoprotein in amniotic fluid as an aid in the diagnosis of neural tube defects.. Clinical Chemistry. 27(10). 1658–1660. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026